非心脏相关疾病负担与活动受限对老年心衰患者结局的影响
本研究基于美国五个整合医疗系统114553例心衰患者(平均73岁,46%女性)的回顾性队列,按非心脏疾病数目(<3 vs ≥3)和活动受限(使用/不使用轮椅、手杖或助行器)分为四组。结果显示,活动受限与非心脏多病负担对全因死亡存在叠加关联,合并两者者死亡风险最高(HR 1.93),且活动受限在<65岁患者中影响最突出。
要点
- 心衰患者中,活动受限与非心脏多病负担对全因死亡存在叠加关联,合并两者风险最高。
- 活动受限在<65岁心衰患者中对死亡的影响最为突出。
- 在非心脏多病负担较重的患者中,活动受限未增加任何原因或心衰相关住院风险。
核心结论
- 活动受限独立于非心脏多病负担,与心衰患者全因死亡风险存在叠加关联,且在年轻患者中更突出。
研究设计与样本
- 回顾性队列研究,纳入美国五个整合医疗系统114553例心衰成人患者,平均年龄73岁,46%为女性。
主要发现
- 与<3种非心脏疾病且无活动受限者相比,<3种非心脏疾病伴活动受限者全因死亡HR为1.40(95%CI 1.31-1.51)。
- ≥3种非心脏疾病且无活动受限者全因死亡HR为1.72(95%CI 1.69-1.75),≥3种非心脏疾病伴活动受限者HR为1.93(95%CI 1.85-2.01)。
- 在非心脏多病负担较重的患者中,未观察到活动受限与任何原因或心衰相关住院风险增加有关。
- 按年龄、性别和心衰类型(射血分数保留、降低、中间值)分组分析,死亡结果一致,活动受限在<65岁患者中影响最突出。
关键数值与推荐
- 非心脏疾病数目按<3种 vs ≥3种分类,活动受限按使用/不使用轮椅、手杖或助行器定义。
- 结局包括全因死亡和心衰或任何原因住院,采用校正后风险比(HR)及95%CI报告。
临床怎么用
- 对心衰患者评估时,除非心脏多病负担外,应关注活动受限(轮椅、手杖或助行器使用),因其与死亡风险叠加相关。
- 年轻心衰患者(<65岁)若存在活动受限,死亡风险关联更突出,临床管理需重视。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To examine the individual and combined associations of noncardiac-related conditions and mobility limitation with morbidity and mortality in adults with heart failure (HF). METHODS: We conducted a retrospective cohort study in a large, diverse group of adults with HF from five U.S. integrated healthcare delivery systems. We characterized patients with respect to the presence of noncardiac conditions (<3 vs ≥3) and/or mobility impairment (defined by the use/nonuse of a wheelchair, cane, or walker), categorizing them into four subgroups. Outcomes included all-cause death and hospitalizations for HF or any cause. RESULTS: Among 114,553 adults diagnosed with HF (mean age: 73 years old, 46% women), compared with <3 noncardiac conditions/no mobility limitation, adjusted hazard ratios (HR) for all-cause death among those with <3 noncardiac conditions/mobility limitation, ≥3 noncardiac conditions/no mobility limitation, ≥3 noncardiac conditions/mobility limitation (vs) were 1.40 (95% CI, 1.31-1.51), 1.72 (95% CI, 1.69-1.75), and 1.93 (95% CI, 1.85-2.01), respectively. We did not observe an increased risk of any-cause or HF-related hospitalization related to the presence of mobility limitation among those with a greater burden of noncardiac multimorbidity. Consistent findings regarding mortality were observed within groups defined according to age, gender, and HF type (preserved, reduced, mid-range ejection fraction), with the most prominent impact of mobility limitation in those <65 years of age. CONCLUSIONS: There is an additive association of mobility limitation, beyond the burden of noncardiac multimorbidity, on mortality for patients with HF, and especially prominent in younger patients.
引用
- Tisminetzky M, Gurwitz JH, Fan D, et al. Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31813983. doi:10.1093/gerona/glz285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。